Munich-based biotech company HMNC Brain Health, focused on the development of personalised therapies in psychiatry, has received an additional €9 million from its current investors.
The supplemental investment brings the total raised to date to €28 million and will strengthen HMNC’s financial position in advance of an expected Series B round later this year.
The investment, in the form of...
Houston-based BrainCheck, developer of a mobile neurocognitive assessment platform, has raised $1.5 million to expand sales, distribution channels, and research opportunities for its product. True Wealth Ventures led the latest round, which, together with the company’s previous raise of $3 million, brings BrainCheck’s total to $4.5 million.
BrainCheck was established in 2014 in a mission to...
